FRANK E. THOMAS - 29 May 2024 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
Director
Signature
/s/ Satyavrat Shukla, Attorney-in-Fact for Frank E. Thomas
Issuer symbol
SPRO
Transactions as of
29 May 2024
Net transactions value
$0
Form type
4
Filing time
30 May 2024, 16:15:59 UTC
Previous filing
15 Feb 2024
Next filing
14 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Award $0 +20,000 +57% $0.000000 55,000 29 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on May 29, 2025, subject to the Reporting Person's continued service through the applicable vesting date.